ISSN: 2278-0238

薬学および生命科学における研究開発の国際ジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

WOUND HEALING ACTIVITY FROM THE LEAF EXTRACTS OF MORUS LAEVIGATA AND IN SILICO BINDING STUDIES FROM ITS ISOLATES WITH GSK 3-�?²

Aditya Rao SJ, Jeevitha B, Smitha R, Ramesh CK, Paramesha M, Jamuna KS

Background: Morus plant species possess enormous importance in the field of medicine and Morus laevigata, a white variety of genus Morus, is a popular hybrid species which is highly appreciated for its medicinal properties.
Methods: The present investigation is aimed to study the effect on wound healing capacity of different solvent extracts of Morus laevigata. Further, In-silico binding studies were carried out for a different drug candidates isolated from Morus laevigata taking nitrofurazone as a standard reference and CHIR-98014 as a positive control against glycogen synthase kinase 3-β (GSK3- β) protein.
Results: The results of the wound healing studies revealed that the methanolic extract has better wound healing activity in terms of mean time of epithelization (18.53±0.33 days) and wound breaking strength (1258.33±59.74) when compared to nitrofurazone (16.36±0.08 days and 1683.33±20.28). Further, the results of the virtual screening revealed that among the three molecules tested, morusin showed minimum binding (-9.47 kJ mol-1) and docking energy (-11.35 kJ mol-1) when compared with the standard reference nitrofurazone (-6.03 kJ mol-1 and -6.29 kJ mol-1).
Conclusion: the active constituents isolated from Morus laevigata supports the wound healing ability of the different solvent extracts in terms of different binding models.